MedTrace Logo

The Impact of the COVID-19 Pandemic on Diabetes Management

NCT04821921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1503

Last updated 2022-11-04

No results posted yet for this study

Summary

The "CoDiaM study" examines how diabetes management and outcomes are changing during the COVID-19 pandemic and whether these changes are influenced by socio-demographic factors, health literacy, self-efficacy and perceived social support.

Conditions

Interventions

OTHER

No intervention

Care as usual

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Ingmar Schäfer, Dr. phil. · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-09
Primary Completion
2022-09-15
Completion
2022-09-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04821921 on ClinicalTrials.gov